참고문헌
- Anderson JR, Armitage JO, Weisenburger DD (1998). Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol, 9, 717-20. https://doi.org/10.1023/A:1008265532487
- Balasubramanium G, Saoba S, Sarade M, Pinjare S (2013). Case-control study of risk factors for non-Hodgkin lymphoma in Mumbai, India. Asian Pac J Cancer Prev, 14, 775-80. https://doi.org/10.7314/APJCP.2013.14.2.775
- Bofetta P (2011). Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol, 22, 27-31. https://doi.org/10.1093/annonc/mdr287
- Dominik D. Alexander, Pamela J, et al (2007). The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer, 120, 1-39.
- Elis A, Blickstein B, Klein O, et al (2002). Detection of relapse in non- Hodgkin's lymphoma : role of routine follow up studies. Am J Hematol, 69, 41-4. https://doi.org/10.1002/ajh.10017
- Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. https://doi.org/10.1016/j.ejca.2008.10.026
- Hussain MA, Pati S, Swain S , et al (2012). Pattern and trends of cancer in Odisha, India: a retrospective study. Asian Pac J Cancer Prev, 13, 6333-36. https://doi.org/10.7314/APJCP.2012.13.12.6333
- Mertsoylu H, Muallaoglu S, Besen AA, et al (2014). Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey. Asian Pac J Cancer Prev, 15, 7207-11. https://doi.org/10.7314/APJCP.2014.15.17.7207
- Naresh KN, Srinivas V, Soman CS (2000). Distribution of various subtypes of non-Hodgkin's lymphoma in India: astudy of 2773 lymphomas using REAL and WHO Classifications. Ann Oncol, 11, 63-7.
- Padhi S, Paul TR, Challa S, et al (2012). Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis. Asian Pac J Cancer Prev, 13, 4889-95. https://doi.org/10.7314/APJCP.2012.13.10.4889
- Sader-Ghorra C, Rassy M, Naderi S, Kourie HR, Kattan J (2014). Type distribution of lymphomas in Lebanon: five-year single institution experience. Asian Pac J Cancer Prev, 15, 5825-8. https://doi.org/10.7314/APJCP.2014.15.14.5825
- SallesG,Shipp MA, Coiffier B (1994). Chemotherapy of non-Hodgkin's aggressive lymphomza. Semi Hematol, 31, 46-69.
- Schuetz JM, Daley D, Leach S, et al (2013). Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development. PLoS One, 8, 75170. https://doi.org/10.1371/journal.pone.0075170
- Sengar M, Akhade A, Nair R, et al (2011). A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center. Indian J Med Paediatr Oncol, 32, 197-203 https://doi.org/10.4103/0971-5851.95140
- Smedby KE (2006). Epidemiology and etiology of non-Hodgkin lymphoma a review. Acta Oncol, 45, 258-71 https://doi.org/10.1080/02841860500531682
- Zelenetz AD, Abramson JS, Advani RJ et al (2011). Non Hodgkin's lymphomas. J Natl Compr Canc Netw, 9, 484-560
- Zhou JY, He LW, Liu J, et al (2014). Comprehensive assessment of associations between ercc2 lys751gln/asp312asn polymorphisms and risk of non-Hodgkin lymphoma. Asian Pac J Cancer Prev, 15, 9347-53. https://doi.org/10.7314/APJCP.2014.15.21.9347